Streetbeat News

Earnings

ASO

FDX

LULU

NKE

WELL

Numerous companies are scheduled to report their earnings on March 21, 2024, covering a wide range of industries from technology to healthcare. The reports include a mix of expected quarterly earnings and losses, with notable companies such as Welltower, Academy Sports, Exscientia, Direxion Daily CSI China Internet Index Bull 2X Shares, and Winnebago Industries among those reporting before the bell. After the bell, companies like Lululemon Athletica, Nike, FedEx, and Intellicheck will report, providing insights into their financial health and performance.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 10:15 am

XFOR

X4 Pharmaceuticals (NASDAQ:XFOR) reported Q4 earnings, beating estimated earnings by 33.0% with an EPS of $-0.1 versus an estimate of $-0.15. However, revenue was unchanged from the same period last year. In the previous quarter, despite beating EPS estimates, the share price dropped by 5.0% the following day.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 10:15 am

LI

Li Auto Inc (NASDAQ:LI) shares dropped premarket Thursday after the company reduced its Q1 FY24 vehicle delivery guidance from 100,000-103,000 to 76,000-78,000, citing lower-than-expected order intake. The adjustment reflects a strategic shift back to focusing on core user groups and cities with higher purchasing power, aiming for sustainable growth by enhancing user value over competition.

Portfolio Pulse from Lekha Gupta

March 21, 2024 | 10:13 am

SCVL

Shoe Carnival reported Q4 earnings of $0.57 per share, missing the consensus estimate of $0.59, and sales of $280.17M, slightly below the estimate of $280.27M. This represents a decrease in both earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:13 am

RMTI

Rockwell Medical forecasts its net sales to increase in the mid-to-high single digits by 2025, with a projected gross margin of around 20% in 2025 and exceeding 25% in 2026 and beyond.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:11 am

SNDL

SNDL reported Q4 sales of $182.55M, surpassing the $178.85M estimate, marking a 2.07% beat but reflecting a 24.07% decrease from the previous year's $240.41M.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:11 am

LU

Lufax Holding (NYSE:LU) reported Q4 earnings with a significant miss, posting an EPS of $-0.21 against an estimate of $-0.02, and a revenue decrease of $820.24 million from the previous year. This follows a pattern of missed EPS estimates in previous quarters, notably leading to a 19.0% share price drop after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 10:10 am

RMTI

Rockwell Medical (NASDAQ:RMTI) reported Q4 earnings, beating estimates with an EPS of $0.02 against an expected -$0.07 and revenue increase of $2.78M from the previous year. The company has a history of surpassing EPS estimates, leading to a share price increase of 13.0% the day after last quarter's earnings were announced.

Portfolio Pulse from Benzinga Insights

March 21, 2024 | 10:10 am

BNOX

Bionomics shares surged following the announcement of positive results from the Phase 2b ATTUNE trial of BNC210 for treating post-traumatic stress disorder.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 10:09 am

LU

Lufax Holding (NYSE:LU) reported Q4 losses of $(0.21) per share, missing the $(0.02) estimate by 950%, and a 5% decrease from last year's $(0.20) per share. Sales were $965.76M, missing the $1.05B estimate by 8.02%, and a 45.93% decrease from last year's $1.79B.

Portfolio Pulse from dijoy@benzinga.com

March 21, 2024 | 10:06 am